Cargando…

5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice

The accumulation of amyloid β (Aβ) in the brain is a major pathological feature of Alzheimer’s disease (AD). In our previous study, we demonstrated that coffee polyphenols (CPP) prevent cognitive dysfunction and Aβ deposition in the brain of an APP/PS2 transgenic mouse AD model. The underlying mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Keiko, Misawa, Koichi, Nishimura, Hitomi, Hirata, Tomoya, Yamamoto, Masaki, Ota, Noriyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071270/
https://www.ncbi.nlm.nih.gov/pubmed/32075202
http://dx.doi.org/10.3390/nu12020494
_version_ 1783506163237650432
author Ishida, Keiko
Misawa, Koichi
Nishimura, Hitomi
Hirata, Tomoya
Yamamoto, Masaki
Ota, Noriyasu
author_facet Ishida, Keiko
Misawa, Koichi
Nishimura, Hitomi
Hirata, Tomoya
Yamamoto, Masaki
Ota, Noriyasu
author_sort Ishida, Keiko
collection PubMed
description The accumulation of amyloid β (Aβ) in the brain is a major pathological feature of Alzheimer’s disease (AD). In our previous study, we demonstrated that coffee polyphenols (CPP) prevent cognitive dysfunction and Aβ deposition in the brain of an APP/PS2 transgenic mouse AD model. The underlying mechanisms, however, remain to be elucidated. Here, we investigated the effects of the chronic administration of 5-caffeoylquinic acid (5-CQA), the most abundant component of CPP, on cognitive dysfunction in APP/PS2 mice to identify the role of CPP in Aβ elimination. Relative to the untreated controls, the mice fed a 5-CQA-supplemented diet showed significant improvements in their cognitive function assessed by Y-maze and novel object recognition tests. Histochemical analysis revealed that 5-CQA substantially reduced Aβ plaque formation and neuronal loss in the hippocampi. Moreover, 5-CQA upregulated the gene encoding low-density lipoprotein receptor-related protein 1, an Aβ efflux receptor, and normalized the perivascular localization of aquaporin 4, which facilitates Aβ clearance along the paravascular pathway. These results suggest that 5-CQA reduces Aβ deposition in the brain by modulating the Aβ clearance pathways and ameliorating cognitive decline and neuronal loss in APP/PS2 mice. Thus, 5-CQA may be effective in preventing cognitive dysfunction in AD.
format Online
Article
Text
id pubmed-7071270
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70712702020-03-19 5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice Ishida, Keiko Misawa, Koichi Nishimura, Hitomi Hirata, Tomoya Yamamoto, Masaki Ota, Noriyasu Nutrients Article The accumulation of amyloid β (Aβ) in the brain is a major pathological feature of Alzheimer’s disease (AD). In our previous study, we demonstrated that coffee polyphenols (CPP) prevent cognitive dysfunction and Aβ deposition in the brain of an APP/PS2 transgenic mouse AD model. The underlying mechanisms, however, remain to be elucidated. Here, we investigated the effects of the chronic administration of 5-caffeoylquinic acid (5-CQA), the most abundant component of CPP, on cognitive dysfunction in APP/PS2 mice to identify the role of CPP in Aβ elimination. Relative to the untreated controls, the mice fed a 5-CQA-supplemented diet showed significant improvements in their cognitive function assessed by Y-maze and novel object recognition tests. Histochemical analysis revealed that 5-CQA substantially reduced Aβ plaque formation and neuronal loss in the hippocampi. Moreover, 5-CQA upregulated the gene encoding low-density lipoprotein receptor-related protein 1, an Aβ efflux receptor, and normalized the perivascular localization of aquaporin 4, which facilitates Aβ clearance along the paravascular pathway. These results suggest that 5-CQA reduces Aβ deposition in the brain by modulating the Aβ clearance pathways and ameliorating cognitive decline and neuronal loss in APP/PS2 mice. Thus, 5-CQA may be effective in preventing cognitive dysfunction in AD. MDPI 2020-02-14 /pmc/articles/PMC7071270/ /pubmed/32075202 http://dx.doi.org/10.3390/nu12020494 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ishida, Keiko
Misawa, Koichi
Nishimura, Hitomi
Hirata, Tomoya
Yamamoto, Masaki
Ota, Noriyasu
5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice
title 5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice
title_full 5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice
title_fullStr 5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice
title_full_unstemmed 5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice
title_short 5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice
title_sort 5-caffeoylquinic acid ameliorates cognitive decline and reduces aβ deposition by modulating aβ clearance pathways in app/ps2 transgenic mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071270/
https://www.ncbi.nlm.nih.gov/pubmed/32075202
http://dx.doi.org/10.3390/nu12020494
work_keys_str_mv AT ishidakeiko 5caffeoylquinicacidamelioratescognitivedeclineandreducesabdepositionbymodulatingabclearancepathwaysinappps2transgenicmice
AT misawakoichi 5caffeoylquinicacidamelioratescognitivedeclineandreducesabdepositionbymodulatingabclearancepathwaysinappps2transgenicmice
AT nishimurahitomi 5caffeoylquinicacidamelioratescognitivedeclineandreducesabdepositionbymodulatingabclearancepathwaysinappps2transgenicmice
AT hiratatomoya 5caffeoylquinicacidamelioratescognitivedeclineandreducesabdepositionbymodulatingabclearancepathwaysinappps2transgenicmice
AT yamamotomasaki 5caffeoylquinicacidamelioratescognitivedeclineandreducesabdepositionbymodulatingabclearancepathwaysinappps2transgenicmice
AT otanoriyasu 5caffeoylquinicacidamelioratescognitivedeclineandreducesabdepositionbymodulatingabclearancepathwaysinappps2transgenicmice